We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+0.87%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$116M
AUM Growth
+$2.62M
Cap. Flow
-$51.8M
Cap. Flow %
-44.69%
Top 10 Hldgs %
59.2%
Holding
174
New
31
Increased
29
Reduced
37
Closed
58

Top Buys

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$1.83M
2
HIVE
Aerohive Networks
HIVE
+$558K
3
DYNC
Vistra Energy Corp.
DYNC
+$553K
4
APTI
Apptio, Inc. Class A Common Stock
APTI
+$551K
5
IWN icon
iShares Russell 2000 Value ETF
IWN
+$470K

Top Sells

Rank Stock Value
1
DY icon
Dycom Industries
DY
+$1.11M
2
MTSI icon
MACOM Technology Solutions
MTSI
+$898K
3
ACOR
Acorda Therapeutics
ACOR
+$770K
4
VRSN icon
VeriSign
VRSN
+$723K
5
GLNG icon
Golar LNG
GLNG
+$714K

Sector Composition

Rank Sector Weight
1 Technology 8.02%
2 Consumer Discretionary 4.35%
3 Communication Services 3.58%
4 Financials 2.11%
5 Real Estate 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLF icon
76
Cleveland-Cliffs
CLF
$6.81B
$184K 0.16%
26,600
-10,500
-28% -$69.5K
ARAV
77
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
$163K 0.14%
3,667
+1,350
+58% +$145K
OVV icon
78
Ovintiv
OVV
$17.5B
$136K 0.12%
3,096
-604
-16% -$31.3K
MWA icon
79
Mueller Water Products
MWA
$3.92B
$135K 0.12%
11,521
-2,540
-18% -$29.2K
ZGNX
80
PUT
DELISTED
Zogenix, Inc.
ZGNX
$104K 0.09%
+25,600
New +$322K
IMMU
81
PUT
DELISTED
Immunomedics Inc
IMMU
$95K 0.08%
+56,800
New +$399K
LPCN icon
82
Lipocine
LPCN
$17.1M
$93K 0.08%
+1,364
New +$89K
TVRD
83
PUT
Tvardi Therapeutics
TVRD
$23.5M
$92K 0.08%
+800
New +$508K
TVRD
84
Tvardi Therapeutics
TVRD
$23.5M
$50K 0.04%
+89
New +$56.5K
TTPH
85
PUT
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$44K 0.04%
+3,630
New +$561K
PALI icon
86
CALL
Palisade Bio
PALI
$339M
$43K 0.04%
+1
New +$439K
PALI icon
87
PUT
Palisade Bio
PALI
$339M
– –
0
– –
LPCN icon
88
PUT
Lipocine
LPCN
$17.1M
$28K 0.02%
1,371
+800
+140% +$52.2K
TGA
89
DELISTED
Transglobe Energy Corp
TGA
$28K 0.02%
21,030
– –
INTC icon
90
PUT
Intel
INTC
$466B
$20K 0.02%
+25,600
New +$916K
MNK
91
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$20K 0.02%
+12,800
New +$561K
NXPI icon
92
CALL
NXP Semiconductors
NXPI
$68B
$17K 0.01%
6,100
-16,200
-73% -$1.74M
RCKT icon
93
CALL
Rocket Pharmaceuticals
RCKT
$348M
$12K 0.01%
15,675
+1,825
+13% +$13.6K
NXPI icon
94
PUT
NXP Semiconductors
NXPI
$68B
$9K 0.01%
+15,500
New +$1.66M
ANIP icon
95
PUT
ANI Pharmaceuticals
ANIP
$1.77B
$8K 0.01%
16,700
-8,000
-32% -$386K
LPCN icon
96
CALL
Lipocine
LPCN
$17.1M
$6K 0.01%
1,424
+800
+128% +$52.2K
ZGNX
97
CALL
DELISTED
Zogenix, Inc.
ZGNX
$6K 0.01%
5,300
-65,700
-93% -$826K
VGR
98
PUT
DELISTED
Vector Group Ltd.
VGR
$5K ﹤0.01%
29,381
+24,647
+521% +$324K
HWM icon
99
PUT
Howmet Aerospace
HWM
$116B
$4K ﹤0.01%
+33,252
New +$678K
IVC
100
PUT
DELISTED
Invacare Corporation
IVC
$3K ﹤0.01%
+12,800
New +$168K
2 3
4
5 6

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
QCA
Quantify Chaos Advisors Brooklyn, New York $32.1M AUM
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Worth Venture Partners's Q2 2017 Portfolio in Review

As of Q2 2017, Worth Venture Partners held 174 positions worth $116M, up 2.3% from $113M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Worth Venture Partners withdrew a net $51.8M in Q2 2017, closing 58 positions and reducing 37 holdings. Its most notable exit was Dycom Industries, an estimated $1.11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8% of assets, up from 7.9% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Worth Venture Partners opened a new position in Arista Networks worth $1.9M.

  • Worth Venture Partners's largest Q2 2017 buy was Arista Networks: 202,576 shares worth $1.9M.
  • Worth Venture Partners added most to Airgain in Q2 2017, an estimated $325K increase.
  • Worth Venture Partners's biggest Q2 2017 reduction was Alphabet (Google) Class C, cutting an estimated $476K.
  • Worth Venture Partners fully exited Dycom Industries in Q2 2017, selling an estimated $1.11M.
  • Worth Venture Partners's ten largest holdings make up 59% of its $116M portfolio in Q2 2017.
  • Worth Venture Partners opened 31 new positions and closed 58 in Q2 2017.
  • Worth Venture Partners's portfolio value rose 2.3% quarter-over-quarter to $116M.

Based on Worth Venture Partners's 13F filing for Q2 2017, filed 11 Aug 2017.